Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates Life Science Investing
Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology Psychedelics Investing
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024 Life Science Investing
Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing Company News
Seelos Therapeutics Announces Notice of Delisting from Nasdaq and Transfer of Listing to Over-the-Counter Market Life Science Investing
